Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Age 18 years or greater
Biopsy-proven breast malignancy
\>/= 1 viable lesion, \>/= 1 cm, confirmed on CT, MR, or FDG PET/CT within 4 weeks of protocol enrollment
Newly diagnosed or recurrent disease, on or off therapy
ECOG performance of 0-2 \*Note: Lesions are considered viable if they are stable or increasing soft tissue lesions, or if they are FDG-avid bone lesions
You may not be if
Life expectancy \< 3 months
Pregnancy or lactation
Biopsy or other surgical procedures within 48 hours prior to receiving study intervention
Patients who cannot undergo PT/CT scanning because of weight limits. PET/CT scanners may not be able to function with patients over 400 pounds
Clareo Health | Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer
